Migraine sufferers speak: which drug works better?
NCT ID NCT06680206
First seen Jan 25, 2026 · Last updated May 12, 2026 · Updated 19 times
Summary
This study looked at survey data from over 1,300 people with migraine to compare how satisfied they were with two types of acute treatments: rimegepant (Nurtec) and triptans. Researchers measured quality of life, work productivity, and disability. The goal was to see if one treatment led to better patient experiences than the other.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer
New York, New York, 10001, United States
Conditions
Explore the condition pages connected to this study.